Entity family
Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.
Showing 8,701–8,760 of 18,081, ordered by supporting articles. Choose a disease to see its evidence.
…of branch retinal vein occlusion (BRVO), central RVO (CRVO) and diabetic retinopathy (DR).Methods The 29×24 mm retinal images from the posterior pol…
…assessment characterizing the immunopeptidome of 10 HNSCC and 3 NSCLC cell lines derived from 9 different patients, revealed 74,578 u…
…ckground Early relapse remains a major challenge in early-stage hepatocellular carcinoma (HCC), with only 30% achieving complete pathological responses …
…3-CAR-NK cells resulted in potent antitumor activity in vivo. 1 Multiple myeloma is a plasma cell cancer that develops in the bone marrow and re…
…ng osteosarcoma (143B, SAOS2), rhabdomyosarcoma (RD, Rh30), and Ewing Sarcoma (TC71), were evaluated by ELISA for TGFB cytokine secretion. We…
…and concurrent stereotactic radiosurgery in immunotherapy-naïve melanoma brain metastases. Cancers (Basel). 2024 Nov 5;16(22):3733. doi:…
…e production potential was assessed. Killing assays using human AML cell lines and healthy T cells were also performed. Statistical…
…esponse to ICIs (p=0.7) (figure 1E). In patients with localized ccRCC undergoing nephrectomy, circulating plasma GDF-15 levels decrea…
…Background Glioblastoma (GBM) is an aggressive brain tumor with a poor prognosis. Only …
…T cells (Tregs; 8.09% vs. 4.18%, P < 0.05) in anti-PD-1-treated NSCLC patients compared to untreated controls. These findings implica…
…Background Oesophageal cancer (EC) is a common cause of cancer mortality. Evidence on the bur…
…lucagon-like peptide-1 receptor agonist (GLP-1RA) used to treat type 2 diabetes mellitus (T2D), has potential associations with higher rates of diabetic retin…